BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6893581)

  • 1. Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse.
    Meyer RA; Gray RW; Meyer MH
    Endocrinology; 1980 Nov; 107(5):1577-81. PubMed ID: 6893581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma 1,25-dihydroxyvitamin D after low calcium challenge in X-linked hypophosphatemic mice.
    Meyer RA; Gray RW; Roos BA; Kiebzak GM
    Endocrinology; 1982 Jul; 111(1):174-7. PubMed ID: 6896304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that low plasma 1,25-dihydroxyvitamin D causes intestinal malabsorption of calcium and phosphate in juvenile X-linked hypophosphatemic mice.
    Meyer RA; Meyer MH; Gray RW; Bruns ME
    J Bone Miner Res; 1987 Feb; 2(1):67-82. PubMed ID: 3455158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 25-hydroxyvitamin D3 in renal slices from the X-linked hypophosphatemic (Hyp) mouse: abnormal response to fall in serum calcium.
    Tenenhouse HS
    Cell Calcium; 1984 Feb; 5(1):43-55. PubMed ID: 6608994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal 24-hydroxylation of 25-hydroxyvitamin D in the X-linked hypophosphatemic mouse.
    Cunningham J; Gomes H; Seino Y; Chase LR
    Endocrinology; 1983 Feb; 112(2):633-8. PubMed ID: 6600222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable phosphate-mediated regulation of vitamin D metabolism in the murine hypophosphatemic rachitic/osteomalacic disorders.
    Davidai GA; Nesbitt T; Drezner MK
    Endocrinology; 1991 Mar; 128(3):1270-6. PubMed ID: 1999147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Jones G
    J Clin Invest; 1990 May; 85(5):1450-5. PubMed ID: 2332500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 24,25-dihydroxyvitamin D3 concentrations in X-linked hypophosphatemic mice: studies using mass fragmentographic and radioreceptor assays.
    Cunningham J; Coldwell RD; Jones G; Tenenhouse HS; Trafford DJ; Makin HL
    J Bone Miner Res; 1990 Feb; 5(2):173-7. PubMed ID: 2316405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1,25-dihydroxyvitamin D3 on phosphate homeostasis in the X-linked hypophosphatemic (Hyp) mouse.
    Tenenhouse HS; Scriver CR
    Endocrinology; 1981 Aug; 109(2):658-60. PubMed ID: 6894727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
    J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phosphate supplementation on the expression of the mutant phenotype in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Martel J; Rubin J; Harvey N
    Bone; 1994; 15(6):677-83. PubMed ID: 7873297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L
    J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE; Glorieux FH
    Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF
    Am J Dis Child; 1980 Feb; 134(2):140-3. PubMed ID: 6243443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased intestinal absorption of calcium in young and adult X-linked hypophosphatemic mice after the administration of 1,25-dihydroxyvitamin D3.
    Meyer MH; Meyer RA
    J Bone Miner Res; 1988 Apr; 3(2):151-7. PubMed ID: 3213610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse.
    Gundberg CM; Clough ME; Carpenter TO
    Endocrinology; 1992 Apr; 130(4):1909-15. PubMed ID: 1547718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ; Travers R; Glorieux FH
    Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
    Scriver CR; Reade TM; DeLuca HF; Hamstra AJ
    N Engl J Med; 1978 Nov; 299(18):976-9. PubMed ID: 308618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS; Yip A; Jones G
    J Clin Invest; 1988 Feb; 81(2):461-5. PubMed ID: 3339128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.